TG Therapeutics (TGTX) Stock Price, Quote, News & History | Benzinga

SPY775.09+0.71%QQQ755.47+0.79%BTC/USD85,582.01−1.08%DIA512.42+0.26%GLD379.47−0.18%TLT76.94−0.70%

TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History

TGTXNASDAQ

Trade with Public

Trade with Public

$54.11

-0.18-0.33%

Last update: Oct 5, 8:05 AM

$54.11

-0.18-0.33%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$54.35

Close

-

Volume / Avg.

595.02K / 2.05M

Day Range

$53.32 - $54.75

52 Wk Range

26.76 - 59.30

Market Cap

$8.28B

P/E Ratio

19.81

Dividend Yield

-

Exchange

NASDAQ

RSI

44

Short Interest

28.47%

Days to Cover

18.54

Recent TG Therapeutics, Inc. News

Biotech ETF XBI Hits an Interest Rate Wall as 40+ Catalysts Approach

B. Riley sees 40+ biotech catalysts ahead as rising rates pressure XBI, setting up a key test for the sector during the Q3 2026 earnings season.

Chandrima Sanyal

MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday

Dow Jones index gained around 350 points on Friday. MARA Holdings Inc (NASDAQ: MARA) rose sharply, while Bitcoin (CRYPTO: BTC) also traded higher. Other stocks recording gains include Evolution Metals (NASDAQ: EMAT), TRON (NASDAQ: TRON), Bakkt (NYSE: BKKT), Rezolute (NASDAQ: RZLT), Gemini Space Station (NASDAQ: GEMI), Robinhood Markets (NASDAQ: HOOD), Strive (NASDAQ: ASST), Moderna (NASDAQ: MRNA), Coinbase Global (NASDAQ: COIN), Bitdeer Technologies (NASDAQ: BTDR), and Circle Internet Group (NYSE: CRCL).

Avi Kapoor

TG Therapeutics Stock Rises Thursday: What's Driving The Gains?

TG Therapeutics shares are trading higher on Thursday as traders keep leaning into recent upbeat clinical updates around BRIUMVI.

Henry Khederian

Top 3 Health Care Stocks That May Collapse This Quarter

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, but positive price action for TGTX.

Avi Kapoor

TG Therapeutics Stock Is Surging Today: What's Driving The Action?

TG Therapeutics shares are trading higher on Wednesday as positive topline Phase 1 data fuels fresh optimism around pipeline expansion.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

17.88M

Investing Cash Flow (TTM)

21.89M

Financing Cash Flow (TTM)

313.73M

Free Cash Flow (TTM)

17.39M

Capital Expenditure (TTM)

-491.00K

Net Change in Cash (TTM)

353.50M

Analyst Trends and Forecast

2

May

3

1

Jul

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.51B

PE Ratio (TTM)

19.81

PE Ratio (FWD)

25.13

PEG Ratio (TTM)

-

PS Ratio (TTM)

10.83

PB Ratio (TTM)

13.76

Earnings Yield % (TTM)

5.05%

Earnings Yield % (FWD)

3.98%

EV / EBITDA (TTM)

61.07

Price / EBITDA (TTM)

62.11

Price / Free Cash Flow (TTM)

498.03

Book Value / Share

$3.95

Company Debt

Total Debt

$745.39M

LT Debt

$745.39M

LT Debt Issuance (TTM)

$747.66M

LT Debt Repayment (TTM)

-$255.00M

Total Cash

$482.58M

Debt to Equity

1.25

Issuance of Debt (TTM)

$492.66M

Repayment of Debt (TTM)

-$255.00M